← Back to All Filings

UNH CEO Acquires Shares via Dividend Equivalents

Low SignificanceDecember 18, 2025 at 5:36:47 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH CEO Acquires Shares via Dividend Equivalents

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: HEMSLEY STEPHEN J Title: CEO, UHG | Relationship: Director, Officer

Transaction: • Type: Award (Dividend Equivalent) • Shares: 52 • Price: $0.00 • Value: $0 • Owned After (Direct): 427,947.942

Key Insight: This is a routine, non-discretionary acquisition of dividend equivalents on vested deferred stock units, not an open market purchase. It holds no significant trading signal.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The CEO acquired a nominal number of shares as dividend equivalents, a routine, non-discretionary event with a total value of $0.
  • Market Impact: Neutral. This transaction is administrative and has no material impact on the market or stock price.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NameHEMSLEY STEPHEN J
CIK0001180162
Title/PositionCEO, UHG
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA
Security TypeCommon Stock
Shares Involved52
Price Per Share$0.00
Total Value$0
Shares Owned After427947.942
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted52
% of Shares Outstanding<0.00001%
Post-Transaction Ownership (Direct)427,947.942 shares (0.047% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value is $0 and involves only 52 shares, which is negligible for a company with a market capitalization of $291.55 billion.
  • Ownership Concentration: The acquisition represents an infinitesimal increase in the insider's already small direct holding of 0.047%. Including indirect holdings, the insider's total ownership remains around 0.12% of shares outstanding.
  • Transaction Significance: The transaction is classified as low significance. It is a non-cash, non-discretionary event resulting from dividend payments on existing stock units, as noted in the filing's footnotes. It does not reflect a new investment decision by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an administrative acquisition of dividend equivalents with zero market value and does not signal any change in insider sentiment or company fundamentals.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to have any impact on trading volume.
  • Sentiment Indicator: Neutral. This type of filing is routine and carries no bullish or bearish sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote explicitly states: "Represents dividend equivalents paid on vested deferred stock units." This confirms the routine and non-discretionary nature of the transaction.
Topics:#SECFiling#Form4#UNH#UnitedHealth#InsiderTrading#CEO#Dividend#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.